These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3575748)

  • 1. Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease.
    Braak H; Braak E
    Prog Brain Res; 1986; 70():185-212. PubMed ID: 3575748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurono-glial ratios in the frontal cortex of the human cerebrum in normal and pathologic aging (Alzheimer's disease)].
    Orzhekhovskaia NS
    Arkh Anat Gistol Embriol; 1986 Nov; 91(11):5-12. PubMed ID: 3813909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia.
    Ashby EL; Kehoe PG; Love S
    Brain Res; 2010 Dec; 1363():1-10. PubMed ID: 20846516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical responses to sustained and divided attention in Alzheimer's disease.
    Johannsen P; Jakobsen J; Bruhn P; Gjedde A
    Neuroimage; 1999 Sep; 10(3 Pt 1):269-81. PubMed ID: 10458942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.
    Davies CA; Mann DM; Sumpter PQ; Yates PO
    J Neurol Sci; 1987 Apr; 78(2):151-64. PubMed ID: 3572454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlations of the neurobiological changes of aging.
    Procter AW; Francis PT; Lowe SL; Pangalos MN; Steele JE; Bowen DM
    Ann Med Interne (Paris); 1990; 141 Suppl 1():3-6. PubMed ID: 1982048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological and quantatitive capillary changes in aging human brain].
    Wang LN; Xu D; Gui QP; Zhu MW; Zhang HH; Hu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):104-7. PubMed ID: 15171542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of recognition memory with and without recollection in patients with Alzheimer's disease and healthy controls.
    Tendolkar I; Schoenfeld A; Golz G; Fernández G; Kühl KP; Ferszt R; Heinze HJ
    Neurosci Lett; 1999 Mar; 263(1):45-8. PubMed ID: 10218907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age-related features of the microstructure of layer V of human frontal lobe cerebral cortex].
    Tsekhmistrenko TA; Chernykh NA
    Morfologiia; 2012; 142(4):14-8. PubMed ID: 23236885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the mesocortical/prefrontal dopamine neurons on their target cells.
    Thierry AM; Mantz J; Milla C; Glowinski J
    Ann N Y Acad Sci; 1988; 537():101-11. PubMed ID: 3059918
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal development of neurons in the human prefrontal cortex. II. A quantitative Golgi study.
    Mrzljak L; Uylings HB; Kostovic I; van Eden CG
    J Comp Neurol; 1992 Feb; 316(4):485-96. PubMed ID: 1577996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Executive function deficits in normal aging, Alzheimer's disease, and frontotemporal dementia].
    Bherer L; Belleville S; Hudon C
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):181-9. PubMed ID: 15689332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test.
    Warkentin S; Passant U
    Dement Geriatr Cogn Disord; 1997; 8(2):105-9. PubMed ID: 9065323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural interactions in the frontal cortex of a behaving monkey: signs of dependence on stimulus context and behavioral state.
    Aertsen A; Vaadia E; Abeles M; Ahissar E; Bergman H; Karmon B; Lavner Y; Margalit E; Nelken I; Rotter S
    J Hirnforsch; 1991; 32(6):735-43. PubMed ID: 1821420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdensitometric measures of cytoplasmic RNA and total protein in pyramidal neurons of the insular cortex and midfrontal gyrus in patients with Alzheimer's disease.
    Colurso GJ; Kan RK; Anthony A
    Cell Biochem Funct; 1995 Dec; 13(4):287-92. PubMed ID: 8565150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β alters ongoing neuronal activity and excitability in the frontal cortex.
    Kellner V; Menkes-Caspi N; Beker S; Stern EA
    Neurobiol Aging; 2014 Sep; 35(9):1982-91. PubMed ID: 24792906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
    Francis PT; Sims NR; Procter AW; Bowen DM
    J Neurochem; 1993 May; 60(5):1589-604. PubMed ID: 8473885
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of false recognition in Alzheimer's disease and in patients with frontal lobe lesions.
    Budson AE; Sullivan AL; Mayer E; Daffner KR; Black PM; Schacter DL
    Brain; 2002 Dec; 125(Pt 12):2750-65. PubMed ID: 12429602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.